Teva Pharmaceuticals · 1 day ago
Director, Business Finance - US Generics
Parsippany, United States, New Jersey, 07054
Full-time
Onsite
Director/Executive
$159K/yr - $209K/yr
10+ years expTeva Pharmaceuticals is a leading innovative biopharmaceutical company dedicated to addressing patients’ needs. The Director of Business Finance for US Generics will consolidate the P&L, provide financial planning and analysis support, and lead initiatives for new product launches while ensuring effective financial processes.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Lead/support planning process for In-line products (Quarterly, Annual and Long Range Forecasts)
Actively manage quarterly close for US Generics by ensuring local systems tie to the corporate view of the P&L and work with the appropriate parties to reconcile any differences
Prepare all variance analytics within a pressured time frame, utilizing bridges and waterfalls to communicate a high level story to upper management
Develop and manage a bottom-up quarterly forecast process for new products and be able to assess opportunities and risks in the forecast. Communicate significant assumptions to senior management
Analyzes and measures actual results compared to forecast and plan
Analyzes and communicates trends and other financial/operational relationships that may impact future financial performance
Creates ad hoc reports as required by management to enable effective financial and operational decision-making
Delivers financial presentations to key members of the leadership team
Carries out responsibilities in accordance with the organization’s policies, procedures, and state, federal and local laws
Qualification
Required
Bachelor's Degree in Finance/Accounting/Economics required
Minimum of 10 years' experience in financial planning and analysis role, preferably in various capacities or rotations in a pharmaceutical environment
Excellent interpersonal skills, strong ability to interface with senior level management
Demonstrated leadership, communication, and analytical skills
Working knowledge of accounting
Demonstrated advanced Excel & Modeling experience
Demonstrated knowledge of PowerPoint, SAP, SmartView and Hyperion
Knowledge of pharmaceutical or healthcare commercial operations
Demonstrated ability to juggle various priorities and provide finance business partner support to numerous stakeholders
Ability to analyze and understand large scale and cross functional information
Ability to work with large amounts of data
Ability to work with individuals at various levels of the organization in the collaborative manner
Strong analytical financial analysis and critical thinking skills
Strong communication skills
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time and holidays.
Life and Disability Protection: Company paid Life and Disability insurance.
Employee Assistance Program
Employee Stock Purchase Plan
Tuition Assistance
Flexible Spending Accounts
Health Savings Account
Life Style Spending Account
Volunteer Time Off
Paid Parental Leave, if eligible
Family Building Benefits
Virtual Physical Therapy
Accident, Critical Illness and Hospital Indemnity Insurances
Identity Theft Protection
Legal Plan
Voluntary Life Insurance
Long Term Disability and more.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase